This is to intimate that the Board of Directors of the Company at its meeting held on Monday, May 25, 2026 at the registered office of the Company have inter alia approved the Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.4 pts less than Nifty Microcap 250 and 2.5 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Chennai Meenakshi Multispeciality Hospital reported total income of ₹3,815.66 lakhs for FY2026, up 6.4% from ₹3,567.21 lakhs in the previous year. Despite revenue growth, the company posted a net loss of ₹111.72 lakhs, though this is narrower than the previous year's loss of ₹137.37 lakhs. EBITDA margins compressed as other expenses rose to ₹2,006.65 lakhs (from ₹1,898.22 lakhs) while employee costs remained high at ₹972.20 lakhs. The balance sheet shows significant stress with negative equity of ₹307.54 lakhs and negative reserves of ₹1,054.43 lakhs. No dividend was recommended. Auditors Elias George & Co. issued an unmodified opinion, and there was no change in auditors during the year.
The company remains loss-making with severely negative equity, indicating potential solvency concerns. While the loss narrowed and revenue grew modestly, the balance sheet weakness may raise red flags for lenders and investors. The stock at scrip code 523489 may face pressure due to the persistent net loss and negative net worth.